Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Avalanche Biotechnologies, Inc. | 40,000 | reported | 12 May 2021 | tx 16+311,013 |
| CRISPR Therapeutics AG | 30,000 | reported | 15 Jun 2018 | tx 88+7,205,910−10,263,754 |
| Passage BIO, Inc. | 24,000 | reported | 25 May 2023 | tx 11+5,058,523−4,734,769 |
| Audentes Therapeutics, Inc. | 18,000 | reported | 24 Aug 2016 | tx 15+1,824,832−1,771,832 |
| Aligos Therapeutics, Inc. | 15,000 | reported | 23 Jun 2022 | tx 25+3,362,998−4,100,504 |
| Tempest Therapeutics, Inc. | 3,500 | reported | 17 Jun 2022 | tx 7+4,311,825 |
| Gritstone Oncology, Inc. | 0 | reported | 25 Aug 2021 | tx 12+4,485,116−3,560,953 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 May 2023 | GRANT_AWARD | Passage BIO, Inc. | 24,000 | 0.00 USD | deriv |
| 23 Jun 2022 | GRANT_AWARD | Aligos Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 17 Jun 2022 | GRANT_AWARD | Tempest Therapeutics, Inc. | 3,500 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | Passage BIO, Inc. | 24,000 | 0.00 USD | deriv |
| 29 Apr 2022 | PURCHASE | Tempest Therapeutics, Inc. | 2,118,644 | 2.36 USD | first after silence |
| 25 Aug 2021 | OTHER | Gritstone Oncology, Inc. | 6,668 | 0.00 USD | |
| 25 Aug 2021 | OTHER | Gritstone Oncology, Inc. | 6,668 | 0.00 USD | |
| 25 Aug 2021 | OTHER | Gritstone Oncology, Inc. | 6,612 | 0.00 USD | |
| 25 Aug 2021 | OTHER | Gritstone Oncology, Inc. | 128 | 0.00 USD | |
| 25 Aug 2021 | OTHER | Gritstone Oncology, Inc. | 444,744 | 0.00 USD | |
| 25 Aug 2021 | OTHER | Gritstone Oncology, Inc. | 6,612 | 0.00 USD | |
| 01 Jul 2021 | GRANT_AWARD | Tempest Therapeutics, Inc. | 6,635 | — | deriv |
| 25 Jun 2021 | GRANT_AWARD | Tempest Therapeutics, Inc. | 7,377 | — | |
| 25 Jun 2021 | GRANT_AWARD | Tempest Therapeutics, Inc. | 1,171,094 | — | |
| 25 Jun 2021 | GRANT_AWARD | Tempest Therapeutics, Inc. | 997,940 | — | |
| 17 Jun 2021 | GRANT_AWARD | Aligos Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 11 Jun 2021 | OTHER | Aligos Therapeutics, Inc. | 485,979 | 0.00 USD | |
| 11 Jun 2021 | OTHER | Aligos Therapeutics, Inc. | 8,383 | 0.00 USD | |
| 11 Jun 2021 | OTHER | Aligos Therapeutics, Inc. | 2,226 | 0.00 USD | |
| 11 Jun 2021 | OTHER | Aligos Therapeutics, Inc. | 9,719 | 0.00 USD | |
| 11 Jun 2021 | OTHER | Aligos Therapeutics, Inc. | 9,719 | 0.00 USD | |
| 11 Jun 2021 | OTHER | Aligos Therapeutics, Inc. | 8,383 | 0.00 USD | |
| 27 May 2021 | GRANT_AWARD | Passage BIO, Inc. | 16,918 | 0.00 USD | deriv |
| 12 May 2021 | GRANT_AWARD | Avalanche Biotechnologies, Inc. | 40,000 | 0.00 USD | deriv |
| 26 Apr 2021 | OTHER | Aligos Therapeutics, Inc. | 2,226 | 0.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 29 Apr 2022.